raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:567983

Parenteral nutrition-associated cholestasis

Synonyms: PNAC

Type
Particular clinical situation in a disease or syndrome
Group
Disorder
Inheritance
Not applicable
Age of onset
All ages
Status
active

A rare hepatic disease characterized by intrahepatic cholestasis and deterioration of liver function in patients receiving parenteral nutrition for extended periods of time (signs may appear as early as within the first two weeks of initiation of parenteral nutrition). The condition commonly occurs in neonates and usually resolves with transition to enteral feeding, although severe cases may progress to liver fibrosis, cirrhosis, and portal hypertension.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enParenteral nutrition-associated cholestasisPNAC
frCholestase liée à la nutrition parentérale= en
deParenterale Ernährung-assoziierte Cholestase= en
esColestasis asociada a nutrición parenteralCANPT
itColestasi da nutrizione parenterale= en
nlCholestase geassocieerd met parenterale voeding= en
ptColestase associada a nutrição parentérica
plŻywienie parenteralne z towarzyszacą cholestazą= en
csCholestáza spojená s parenterální výživou= en
ukПарентеральний холестаз, асоційований з харчуванням= en
zh肠外营养相关的胆汁淤积症= en
trParenteral beslenme-ilişkili kolestaz= en

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10K76.8NTBTattributedvalidated
ICD-11DB99.60Especificvalidated
MONDO35777Evalidated
UMLSC3274301Evalidated
MedDRA10074151Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

0 direct

Orphanet records no gene directly on this code.

5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Point prevalenceUnknown—WorldwideClass onlyValidatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

22 annotations · validated 2021-06-30
HPOTerm (as annotated by Orphanet)Diagnostic
Frequent (79-30%)
HP:0002027Abdominal pain
HP:0004359Abnormal circulating fatty-acid concentration
HP:0032245Abnormal metabolism
HP:0011113Abnormality of cytokine secretion
HP:0006560Biliary hyperplasia
HP:0003155Elevated circulating alkaline phosphatase concentration
HP:0002910Elevated circulating hepatic transaminase concentration
HP:0030948Elevated gamma-glutamyltransferase level
HP:0001399Hepatic failure
HP:0002240Hepatomegaly
HP:0003077Hyperlipidemia
HP:0000952Jaundice
HP:0001622Premature birth
HP:0001518Small for gestational age
HP:0001744Splenomegaly
HP:0011473Villous atrophy
Occasional (29-5%)
HP:0001081Cholelithiasis
HP:0001394Cirrhosis
HP:0002908Conjugated hyperbilirubinemia
HP:0001395Hepatic fibrosis
HP:0001397Hepatic steatosis
HP:0001409Portal hypertension

Annotation source: 31872510[PMID]_32728621[PMID]

7

Sources for this card